Hosted by & KISAR (Karnataka Chapter of ISAR) ISMAAR (The International Society for Mild Approaches in Assisted Reproduction) Optimizing ART Outcome – through Individualized Protocols @ forthcoming International Congress on 4th and 5th February 2012 at Hotel Atria, Bengaluru
5
Embed
Optimizing ART Outcome – through Individualized Protocolsismaar.org/PDFs/kisar-ismaar brochure v9.pdf · Optimizing ART Outcome – through Individualized ... Madhuri Patil C. Sharath
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Hosted by
&KISAR (Karnataka Chapter of ISAR)
ISMAAR (The International Society for Mild
Approaches in Assisted Reproduction)
Optimizing ART Outcome
– through Individualized
Protocols @
forthcoming International Congress on
4th and 5th February 2012at Hotel Atria, Bengaluru
Dear Friends
“A scientific truth does not triumph by convincing its opponents and making them see the light, but rather because its opponents eventually die and a new generation grows up that is familiar with it.”
Max Planck
ART is associated with health risks to the mother and child. Today, ovulation induction protocols involve several controversies in the drugs used, types of protocol and the risks involved with it. This update on ovarian stimulation will discuss many current strategies for ovarian stimulation, individual variability in ovarian response and its possible implications on oocyte and embryo quality and endometrial receptivity.
Being aware of the complex interplay between the ovarian physiology, ovarian stimulation, in vitro embryo development and IVF outcome will help in optimizing the ART outcome.
This conference aims to present knowledge that can be translated into daily practice by identifying patients who require conventional or mild stimulation for an optimal outcome.
Furthermore, the conference will address the protocols and laboratory systems needed to offer low-cost IVF in developing countries.
Jean Piaget has rightly said “Scientific knowledge is in perpetual evolution; it finds itself changed from one day to the next.”
We await your participation.
Warm Regards
Madhuri Patil C. Sharath Kumar Bina Vasan Devika Gunasheela Geeta NargundPresident Secretary Treasurer Joint Secretary PresidentKISAR (KarnataKa Chapter of ISar) ISMAAR
Course ObjectivesAt the conclusion of this conference the participants should be able to:
• know the effects and risks of Ovulation Induction• critically evaluate the prediction and prevention of OHSS• understand complexity of different ovulation induction protocols in terms of drug and dose used
and desired endpoint• know that individual differences exist in response to ovarian stimulation which are related to
intrinsic ovarian differences and its implications• critically evaluate the value of new methods – Mild and Natural cycle IVF• understand the implications of single embryo transfer• evaluate the value of IVM• identify the best methods to test ovarian reserve and monitor ovulation Induction cycles• understand the implications of low-cost IVF for developing countries
Who should attend?
• Infertility and ART specialist
• Obstetrician and Gynecologist
• Clinical embryologist
• Postgraduate students
Day 1 – Saturday 4th February 2012Session 1 – 9.00 – 10.00 AM effects of conventional CoS on the outcome of art Think before you discard the old……………9.00 – 9.15 AM Impact of COS on oocytes and embryos – Satish Adiga9.15 – 9.30 AM Implications of ovarian stimulation on endometrial receptivity - Bina Vasan9.30 – 9.45 AM DiscussionSession 2 - 09.45 – 10.45 AMOvulation Induction strategiesexciting options for the future09.45 – 10.00 AM Individualizing ovarian stimulation in ART – Korula George10.00 – 10.15 AM Use of oral anti-oestrogens in ART cycles – Prof. Svend Lindenberg10.15 – 10.30 AM OHSS free clinic - Is it a dream? – Reeta Biliangady10.30 – 10.45 AM Discussion10.45 – 11.15 AM Coffee Break11.15 – 11.45 AM Keynote Address
Chairpersons: Kamini Rao, Madhuri PatilMild ART should it become the norm? – Prof. Geeta Nargund
11.45 – 12.15 PM Inauguration12.15 – 1.15 PM
Panel DiscussionStump the experts – point counterpointModerator – Madhuri PatilPanel Members – Svend Lindenberg, Mette Munk, Anuja Kamat, Deepika K, Fessy Louis, Mala Arora, Shobhana Patted
1.15 – 2.15 PM LunchSession 3 – 2.15 – 3.30 PMAll about Mild ARTChanging Attitudes Changing practices2.15 – 2.45 PM IndicationsandroleofnaturalcycleandmodifiednaturalcycleIVFtoday–Prof.GeetaNargund2.45 – 3.00 PM From aggressive to mild stimulation – Is it better? – Kannaki C V3.00 – 3.15 PM Luteal Phase supplementation on Mild/natural cycle ART – Bharati Dorepatil3.15 – 3.30 PM DiscussionSession 4 - 3.30 – 4.00 PM Paper Presentation - Best 3 postersSession 5 - 4.00 – 5.15 PM4.00 – 5.00 PM Debates
Chairpersons: Prof. Willem Ombelet, Prof. Svend Lindenberg4.00 – 4. 30 PM Debate 1
GnRH agonist or Antagonist – which is better in Mild ART?GnRH agonist – B. RameshGnRH Antagonist – Nirmala R
4.30 – 5.00 PM Debate 2Will mild stimulation replace conventional COS in ART practice?For – Sunita TandulwadkarAgainst – Nandita Palshetkar
Chairpersons: Geeta Nargund, Dhiraj GadaLegal Issues in Infertility Practice – Kamini Rao
5.45 – 6.00 PM Discussion
Day 2 – Sunday 5th February 2012Meet the experts – Breakfast Session8.00 - 9.00 AM Topics
1. Explore the protocols - Experts: Prof. Geeta Nargund, Prof. Willem Ombelet, Kamini Rao2. IVM – When and how - Experts: Prof. Svend Lindenberg, Shreyas Padgaonkar, Devika Gunasheela3. Lab aspects of ART - Prof. Mette Munk, Vyjayanthi, Satish Adiga
Session 6 – 9.00 – 10. 15 AMMild Stimulation – Varied options in varied situations 9.00 - 9.15 AM Minimal stimulation protocols in IUI – Prof. Willem Ombelet9.15 – 9.30 AM Natural cycle/Mild stimulation in women with poor ovarian reserve/oocyte donors – Abha Majumdar9.30 – 9.45 AM Minimal stimulation in women with PCOS – Sonia Mallik9.45 – 10.00 AM Role of mild stimulation in fertility preservation in young cancer patients – Mandakini Parihar10.00 – 10.15 AM Discussion10 .15 – 10.45 AM Coffee BreakSession 7 – 10.45 – 12.00 PMUncertainties with IVM – Would they resolve soon?10.45 – 11.15 AM Keynote Address
Does IVM with mild stimulation improve outcome in PCOS? – Prof. Svend Lindenberg11.15 – 11.30 AM IVM in natural and FSH primed cycles – Devika Gunasheela11.30 – 11.45 AM IVM & fertility preservation in Cancer patients – Prof. Mette Munk11.45 – 12.00 PM DiscussionSession 8 – 12.00 – 1.15 PMembryos - are they different?12.00– 12.15 PM Ovarian stimulation and embryo quality - Less is more – Prof. Mette Munk12.15 – 12.30 PM Non invasive assessment of embryo - Does it improve embryo selection and is it cost effective in Indian
Scenario? - Vyjayanthi12.30 – 12.45 PM With Mild ART are we moving towards SET – Shreyas Padgaonkar12.45 – 1.00 PM Are Mild ART derived blastocysts more favorable than conventional COS derived ones? – Srinivas MS 1.00– 1.15 PM Discussion1.15 – 2.00 PM LunchSession 9 – 2.00 – 3.15 PMSafety and affordability – “Do no harm – to the patient and to her pocket”2.00 – 2.15 PM Affordability and access to ART in India – Manish Banker2.15 – 2.30 PM Soft protocols for Indian population – Dhiraj Gada2.30 - 2.45 PM Natural cycle IVF - Is it effective and cost effective? – Nalini Mahajan2.45 – 3.00 PM Discussion3.00– 3.30 PM Keynote Address
Low cost IVF in developing countries – What does it Imply? – Prof. Willem Ombelet3.30 – 4.30 PM Panel Discussion
Ground realities – Can our patients benefit?Impact of Milder stimulation upon indicators of benefit in Indian scenario – efficacy, safety, time, cost and qualityModerator – Mirudhubashini GovindarajanPanel Members – Prof. Willem Ombelet, Abha Majumdar, Asha Gangane, B.R Desai, Jyoti Menon, Kallappa Mavintop, Nivedita Shetty
Session 10 – 4.30 – 5.45 PMSelect Investigations in select situations - Can it reduce the burden?4.30 – 4.45 PM Stem Cells and Ovarian Reserve - Deepa Bhartiya 4.45 – 5.00 PM Assessment of ovarian reserve and its implications on selecting an ideal protocol for COS –
Padmarekha Jirge5.00– 5.15 PM Can use of advanced ultrasound technology make a difference in investigating and treating? –